Allotera Therapeutics, Inc. — Form D

Allotera Therapeutics, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-08. The offering totals $163.0M, of which $109.5M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2025-09-08
• Form: D
• Accession: 0001874298-25-000004
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $163.0M
• Amount sold: $109.5M
• Remaining: $53.6M
• Investors: 20
• Date of first sale: 2025-08-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-556954

Issuer

• Name: Allotera Therapeutics, Inc.
• CIK: 0001874298
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 4260 FOREST PARK AVE., SUITE 100 4260 Forest Park Ave., Suite 100, ST. LOUIS, MO, 63110
• Phone: 314-501-1968

Officers, directors & promoters (35)

Showing 25 of 35 people.

Other filings by this issuer (3)

More

• CIK 1874298 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search